Market Overview:
The global systemic sclerosis treatments market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth can be attributed to the increasing prevalence of systemic sclerosis, rising awareness about available treatment options, and growing demand for novel therapies. The global systemic sclerosis treatments market is segmented on the basis of type and application. On the basis of type, the market is segmented into limited cutaneous systemic sclerosis and diffuse cutaneous systematic sclerosis. Limited cutaneous systematic sclerosis is further sub-segmented into limited scleroderma and CREST syndrome. Diffuse cutaneous systematic sclerosis is further sub-segmented into diffuse scleroderma and SSc-pulmonary hypertension syndrome (SSc-PH). On the basis of application, the market is segmented into hospital pharmacies, drug stores, retail pharmacies, online pharmacies,. Geographically, the global systemic sclerosis treatments market is segmented into North America,, Latin America,, Europe,, Asia Pacificand Middle East & Africa . However,.
Product Definition:
Systemic sclerosis treatments are used to help manage the symptoms of the disease. They may include medications, therapies, and lifestyle changes. Treatment is important because it can help improve quality of life for people with systemic sclerosis.
Limited Cutaneous Systemic Sclerosis:
The limited cutaneous systemic sclerosis market size was valued at USD 1.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The key drivers for this market are increasing prevalence of Systemic Sclerosis (SSc), rising demand for effective therapeutics, and growing awareness about early diagnosis among patients & physicians.
Diffuse Cutaneous Systemic Sclerosis:
Diffuse cutaneous systemic sclerosis (DCCS) is a rare chronic inflammatory demyelinating polyneuropathy characterized by the accumulation of immune cells in the dermis and epidermis. The disease has an incidence rate of 1-2 per 100,000 population annually.
Application Insights:
Based on application, the global systemic sclerosis treatments market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and drug stores. The drug stores held the largest share of over 40% in 2017. Drug store chains including CVS Health Corporation and Walgreens Boots Alliance Inc have been focusing on offering easy to access medicines through their outlets. This has led to an increased number of patients visiting these stores for treatment options.
The hospital pharmacy segment is anticipated to witness lucrative growth during the forecast period owing to rising prevalence of SSc coupled with a high demand for effective treatment options across the globe. Hospital-based systemic sclerosis clinics have been established worldwide where patients can meet with healthcare professionals for diagnosis and appropriate medication management at one place (instead of moving from one place to another seeking medical attention). These initiatives are expected to increase awareness about SSc among general practitioners as well as specialists which will further boost market growth during this forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of pharmaceutical companies and increased R&D activities for development of novel drugs are some factors responsible for its dominance. Moreover, high prevalence rate and improved healthcare facilities in this region also contribute to its growth. In addition, favorable reimbursement policies for systemic sclerosis treatments also help boost revenue generation in this region.
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to increasing disposable income levels and rising patient awareness about available treatment options coupled with growing demand for quality healthcare services resulting from an aging population base especially in Japan & China which account for majority share due to their large population size & economic stability over the forecast period.
Growth Factors:
- Increasing incidence of systemic sclerosis
- Growing awareness about systemic sclerosis and its treatments
- Rising demand for better and more effective systemic sclerosis treatments
- Technological advancements in the field of systemic sclerosis treatments
- Availability of government funding for research on systemic sclerosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Systemic Sclerosis Treatments Market Research Report
By Type
Limited Cutaneous Systemic Sclerosis, Diffuse Cutaneous Systemic Sclerosis
By Application
Hospital Pharmacies, Drug Stores, Retail Pharmacies, Online Pharmacies
By Companies
Cytori Therapeutics, Actelion Pharmaceuticals, Boehringer Ingelheim
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Systemic Sclerosis Treatments Market Report Segments:
The global Systemic Sclerosis Treatments market is segmented on the basis of:
Types
Limited Cutaneous Systemic Sclerosis, Diffuse Cutaneous Systemic Sclerosis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Drug Stores, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cytori Therapeutics
- Actelion Pharmaceuticals
- Boehringer Ingelheim
Highlights of The Systemic Sclerosis Treatments Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Limited Cutaneous Systemic Sclerosis
- Diffuse Cutaneous Systemic Sclerosis
- By Application:
- Hospital Pharmacies
- Drug Stores
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Systemic Sclerosis Treatments Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Systemic sclerosis treatments may include medications, surgery, and other treatments.
Some of the major companies in the systemic sclerosis treatments market are Cytori Therapeutics, Actelion Pharmaceuticals, Boehringer Ingelheim.
The systemic sclerosis treatments market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Systemic Sclerosis Treatments Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Systemic Sclerosis Treatments Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Systemic Sclerosis Treatments Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Systemic Sclerosis Treatments Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Systemic Sclerosis Treatments Market Size & Forecast, 2018-2028
4.5.1 Systemic Sclerosis Treatments Market Size and Y-o-Y Growth
4.5.2 Systemic Sclerosis Treatments Market Absolute $ Opportunity
Chapter 5 Global Systemic Sclerosis Treatments Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Systemic Sclerosis Treatments Market Size Forecast by Type
5.2.1 Limited Cutaneous Systemic Sclerosis
5.2.2 Diffuse Cutaneous Systemic Sclerosis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Systemic Sclerosis Treatments Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Systemic Sclerosis Treatments Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Drug Stores
6.2.3 Retail Pharmacies
6.2.4 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Systemic Sclerosis Treatments Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Systemic Sclerosis Treatments Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Systemic Sclerosis Treatments Analysis and Forecast
9.1 Introduction
9.2 North America Systemic Sclerosis Treatments Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Systemic Sclerosis Treatments Market Size Forecast by Type
9.6.1 Limited Cutaneous Systemic Sclerosis
9.6.2 Diffuse Cutaneous Systemic Sclerosis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Systemic Sclerosis Treatments Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Drug Stores
9.10.3 Retail Pharmacies
9.10.4 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Systemic Sclerosis Treatments Analysis and Forecast
10.1 Introduction
10.2 Europe Systemic Sclerosis Treatments Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Systemic Sclerosis Treatments Market Size Forecast by Type
10.6.1 Limited Cutaneous Systemic Sclerosis
10.6.2 Diffuse Cutaneous Systemic Sclerosis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Systemic Sclerosis Treatments Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Drug Stores
10.10.3 Retail Pharmacies
10.10.4 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Systemic Sclerosis Treatments Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Systemic Sclerosis Treatments Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Systemic Sclerosis Treatments Market Size Forecast by Type
11.6.1 Limited Cutaneous Systemic Sclerosis
11.6.2 Diffuse Cutaneous Systemic Sclerosis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Systemic Sclerosis Treatments Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Drug Stores
11.10.3 Retail Pharmacies
11.10.4 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Systemic Sclerosis Treatments Analysis and Forecast
12.1 Introduction
12.2 Latin America Systemic Sclerosis Treatments Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Systemic Sclerosis Treatments Market Size Forecast by Type
12.6.1 Limited Cutaneous Systemic Sclerosis
12.6.2 Diffuse Cutaneous Systemic Sclerosis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Systemic Sclerosis Treatments Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Drug Stores
12.10.3 Retail Pharmacies
12.10.4 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Systemic Sclerosis Treatments Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Systemic Sclerosis Treatments Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Systemic Sclerosis Treatments Market Size Forecast by Type
13.6.1 Limited Cutaneous Systemic Sclerosis
13.6.2 Diffuse Cutaneous Systemic Sclerosis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Systemic Sclerosis Treatments Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Drug Stores
13.10.3 Retail Pharmacies
13.10.4 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Systemic Sclerosis Treatments Market: Competitive Dashboard
14.2 Global Systemic Sclerosis Treatments Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cytori Therapeutics
14.3.2 Actelion Pharmaceuticals
14.3.3 Boehringer Ingelheim
